NeuBase Therapeutics, Inc.

Ownership Transactions Reported by 11 Insiders

Location
350 Technology Drive, Pittsburgh, PA

There are no Buy or Sell transactions made by insiders since 11/21/2023

NeuBase Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Symetryx Corp 10%+ Owner $370K Sep 14, 2023
Dietrich A. Stephan Founder and CEO, Director, 10%+ Owner $301K Aug 2, 2023
Todd P. Branning Chief Financial Officer $162K Mar 16, 2023
William Mann Chief Operating Officer $21.5K Mar 30, 2022
Sandra Rojas-Caro Chief Medical Officer Jan 24, 2022
Dov A. Goldstein Director Sep 9, 2022
Franklyn G. Prendergast Director Sep 9, 2022
Eric Richman Director Sep 9, 2022
Eric J. Ende Director Sep 9, 2022
J. McDougall Director Sep 9, 2022
Kianoush Motesharei Officer May 24, 2021

Recent Insider Transactions by Companies or Individuals for NeuBase Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.